 | • レポートコード：D0GIR-04904 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、エトリコキシブ中間体の世界市場を広く調査・分析し、今後の市場展望をまとめております。エトリコキシブ中間体の種類別市場規模（社内製造、受託製造企業）、用途別市場規模（関節リウマチ、乾癬性関節炎、変形性関節症、強直性脊椎炎、慢性腰痛、急性痛、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、Merck、Pfizer、Novacap、Kopran、Abbott、GlaxoSmithKline、Perrigo、Geri-Care、Sun Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・エトリコキシブ中間体の北米市場（アメリカ、カナダ、メキシコ） ・エトリコキシブ中間体のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・エトリコキシブ中間体のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・エトリコキシブ中間体の南米市場（ブラジル、アルゼンチン） ・エトリコキシブ中間体の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：社内製造、受託製造企業 ・用途別分析：関節リウマチ、乾癬性関節炎、変形性関節症、強直性脊椎炎、慢性腰痛、急性痛、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Etoricoxib Intermediate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Etoricoxib Intermediate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Etoricoxib Intermediate market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Etoricoxib Intermediate market has been segmented into
n-House Manufacturing
Contract Manufacturing Organizations
By Application, Etoricoxib Intermediate has been segmented into:
Rheumatoid Arthritis
Psoriatic Arthritis
Osteoarthritis
Ankylosing Spondylitis
Chronic Low Back Pain
Acute Pain
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Etoricoxib Intermediate market presented in the report. This section sheds light on the sales growth of different regional and country-level Etoricoxib Intermediate markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Etoricoxib Intermediate market.
The report offers in-depth assessment of the growth and other aspects of the Etoricoxib Intermediate market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Etoricoxib Intermediate Market Share Analysis
Etoricoxib Intermediate competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Etoricoxib Intermediate sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Etoricoxib Intermediate sales, revenue and market share for each player covered in this report.
The major players covered in Etoricoxib Intermediate are:
Bayer
Merck
Pfizer
Novacap
Kopran
Abbott
GlaxoSmithKline
Perrigo
Geri-Care
Sun Pharmaceutical
Among other players domestic and global, Etoricoxib Intermediate market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Etoricoxib Intermediate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Etoricoxib Intermediate, with price, sales, revenue and global market share of Etoricoxib Intermediate in 2018 and 2019.
Chapter 3, the Etoricoxib Intermediate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Etoricoxib Intermediate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Etoricoxib Intermediate market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Etoricoxib Intermediate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Etoricoxib Intermediate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Etoricoxib Intermediate Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 n-House Manufacturing
1.2.3 Contract Manufacturing Organizations
1.3 Market Analysis by Application
1.3.1 Overview: Global Etoricoxib Intermediate Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Rheumatoid Arthritis
1.3.3 Psoriatic Arthritis
1.3.4 Osteoarthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Chronic Low Back Pain
1.3.7 Acute Pain
1.3.8 Others
1.4 Overview of Global Etoricoxib Intermediate Market
1.4.1 Global Etoricoxib Intermediate Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novacap
2.4.1 Novacap Details
2.4.2 Novacap Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novacap SWOT Analysis
2.4.4 Novacap Product and Services
2.4.5 Novacap Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Kopran
2.5.1 Kopran Details
2.5.2 Kopran Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Kopran SWOT Analysis
2.5.4 Kopran Product and Services
2.5.5 Kopran Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abbott SWOT Analysis
2.6.4 Abbott Product and Services
2.6.5 Abbott Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GlaxoSmithKline SWOT Analysis
2.7.4 GlaxoSmithKline Product and Services
2.7.5 GlaxoSmithKline Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Perrigo
2.8.1 Perrigo Details
2.8.2 Perrigo Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Perrigo SWOT Analysis
2.8.4 Perrigo Product and Services
2.8.5 Perrigo Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Geri-Care
2.9.1 Geri-Care Details
2.9.2 Geri-Care Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Geri-Care SWOT Analysis
2.9.4 Geri-Care Product and Services
2.9.5 Geri-Care Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sun Pharmaceutical
2.10.1 Sun Pharmaceutical Details
2.10.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sun Pharmaceutical SWOT Analysis
2.10.4 Sun Pharmaceutical Product and Services
2.10.5 Sun Pharmaceutical Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Etoricoxib Intermediate Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Etoricoxib Intermediate Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Etoricoxib Intermediate Manufacturer Market Share in 2019
3.3.2 Top 6 Etoricoxib Intermediate Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Etoricoxib Intermediate Sales, Revenue and Market Share by Regions
4.1.1 Global Etoricoxib Intermediate Sales and Market Share by Regions (2015-2020)
4.1.2 Global Etoricoxib Intermediate Revenue and Market Share by Regions (2015-2020)
4.2 North America Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
4.3 Europe Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
4.5 South America Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Etoricoxib Intermediate Sales, Revenue and Market Share by Country
5.1.1 North America Etoricoxib Intermediate Sales and Market Share by Country (2015-2020)
5.1.2 North America Etoricoxib Intermediate Revenue and Market Share by Country (2015-2020)
5.2 United States Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
5.3 Canada Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
5.4 Mexico Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Etoricoxib Intermediate Sales, Revenue and Market Share by Country
6.1.1 Europe Etoricoxib Intermediate Sales and Market Share by Country (2015-2020)
6.1.2 Europe Etoricoxib Intermediate Revenue and Market Share by Country (2015-2020)
6.2 Germany Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
6.3 UK Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
6.4 France Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
6.5 Russia Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
6.6 Italy Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Etoricoxib Intermediate Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Etoricoxib Intermediate Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Etoricoxib Intermediate Revenue and Market Share by Regions (2015-2020)
7.2 China Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
7.3 Japan Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
7.4 Korea Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
7.5 India Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
7.7 Australia Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Etoricoxib Intermediate Sales, Revenue and Market Share by Country
8.1.1 South America Etoricoxib Intermediate Sales and Market Share by Country (2015-2020)
8.1.2 South America Etoricoxib Intermediate Revenue and Market Share by Country (2015-2020)
8.2 Brazil Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
8.3 Argentina Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Etoricoxib Intermediate Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Etoricoxib Intermediate Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Etoricoxib Intermediate Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
9.3 Turkey Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
9.4 Egypt Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
9.5 South Africa Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Etoricoxib Intermediate Sales and Market Share by Type (2015-2020)
10.2 Global Etoricoxib Intermediate Revenue and Market Share by Type (2015-2020)
10.3 Global Etoricoxib Intermediate Price by Type (2015-2020)
11 Global Etoricoxib Intermediate Market Segment by Application
11.1 Global Etoricoxib Intermediate Sales Market Share by Application (2015-2020)
11.2 Global Etoricoxib Intermediate Revenue Market Share by Application (2015-2020)
11.3 Global Etoricoxib Intermediate Price by Application (2015-2020)
12 Market Forecast
12.1 Global Etoricoxib Intermediate Sales, Revenue and Growth Rate (2021-2025)
12.2 Etoricoxib Intermediate Market Forecast by Regions (2021-2025)
12.2.1 North America Etoricoxib Intermediate Market Forecast (2021-2025)
12.2.2 Europe Etoricoxib Intermediate Market Forecast (2021-2025)
12.2.3 Asia-Pacific Etoricoxib Intermediate Market Forecast (2021-2025)
12.2.4 South America Etoricoxib Intermediate Market Forecast (2021-2025)
12.2.5 Middle East & Africa Etoricoxib Intermediate Market Forecast (2021-2025)
12.3 Etoricoxib Intermediate Market Forecast by Type (2021-2025)
12.3.1 Global Etoricoxib Intermediate Sales Forecast by Type (2021-2025)
12.3.2 Global Etoricoxib Intermediate Market Share Forecast by Type (2021-2025)
12.4 Etoricoxib Intermediate Market Forecast by Application (2021-2025)
12.4.1 Global Etoricoxib Intermediate Sales Forecast by Application (2021-2025)
12.4.2 Global Etoricoxib Intermediate Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Etoricoxib Intermediate Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Etoricoxib Intermediate by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Etoricoxib Intermediate Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Etoricoxib Intermediate Major Business
Table 9. Bayer Etoricoxib Intermediate Total Revenue (USD Million) (2018-2019)
Table 10. Bayer SWOT Analysis
Table 11. Bayer Etoricoxib Intermediate Product and Services
Table 12. Bayer Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Etoricoxib Intermediate Major Business
Table 15. Merck Etoricoxib Intermediate Total Revenue (USD Million) (2018-2019)
Table 16. Merck SWOT Analysis
Table 17. Merck Etoricoxib Intermediate Product and Services
Table 18. Merck Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Etoricoxib Intermediate Major Business
Table 21. Pfizer Etoricoxib Intermediate Total Revenue (USD Million) (2018-2019)
Table 22. Pfizer SWOT Analysis
Table 23. Pfizer Etoricoxib Intermediate Product and Services
Table 24. Pfizer Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novacap Basic Information, Manufacturing Base and Competitors
Table 26. Novacap Etoricoxib Intermediate Major Business
Table 27. Novacap Etoricoxib Intermediate Total Revenue (USD Million) (2018-2019)
Table 28. Novacap SWOT Analysis
Table 29. Novacap Etoricoxib Intermediate Product and Services
Table 30. Novacap Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Kopran Basic Information, Manufacturing Base and Competitors
Table 32. Kopran Etoricoxib Intermediate Major Business
Table 33. Kopran Etoricoxib Intermediate Total Revenue (USD Million) (2018-2019)
Table 34. Kopran SWOT Analysis
Table 35. Kopran Etoricoxib Intermediate Product and Services
Table 36. Kopran Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Abbott Basic Information, Manufacturing Base and Competitors
Table 38. Abbott Etoricoxib Intermediate Major Business
Table 39. Abbott Etoricoxib Intermediate Total Revenue (USD Million) (2018-2019)
Table 40. Abbott SWOT Analysis
Table 41. Abbott Etoricoxib Intermediate Product and Services
Table 42. Abbott Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Etoricoxib Intermediate Major Business
Table 45. GlaxoSmithKline Etoricoxib Intermediate Total Revenue (USD Million) (2018-2019)
Table 46. GlaxoSmithKline SWOT Analysis
Table 47. GlaxoSmithKline Etoricoxib Intermediate Product and Services
Table 48. GlaxoSmithKline Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Perrigo Basic Information, Manufacturing Base and Competitors
Table 50. Perrigo Etoricoxib Intermediate Major Business
Table 51. Perrigo Etoricoxib Intermediate Total Revenue (USD Million) (2018-2019)
Table 52. Perrigo SWOT Analysis
Table 53. Perrigo Etoricoxib Intermediate Product and Services
Table 54. Perrigo Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Geri-Care Basic Information, Manufacturing Base and Competitors
Table 56. Geri-Care Etoricoxib Intermediate Major Business
Table 57. Geri-Care Etoricoxib Intermediate Total Revenue (USD Million) (2018-2019)
Table 58. Geri-Care SWOT Analysis
Table 59. Geri-Care Etoricoxib Intermediate Product and Services
Table 60. Geri-Care Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Sun Pharmaceutical Etoricoxib Intermediate Major Business
Table 63. Sun Pharmaceutical Etoricoxib Intermediate Total Revenue (USD Million) (2018-2019)
Table 64. Sun Pharmaceutical SWOT Analysis
Table 65. Sun Pharmaceutical Etoricoxib Intermediate Product and Services
Table 66. Sun Pharmaceutical Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Etoricoxib Intermediate Sales by Manufacturer (2018-2019) (MT)
Table 68. Global Etoricoxib Intermediate Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Etoricoxib Intermediate Sales by Regions (2015-2020) (MT)
Table 70. Global Etoricoxib Intermediate Sales Market Share by Regions (2015-2020)
Table 71. Global Etoricoxib Intermediate Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Etoricoxib Intermediate Sales by Countries (2015-2020) (MT)
Table 73. North America Etoricoxib Intermediate Sales Market Share by Countries (2015-2020)
Table 74. North America Etoricoxib Intermediate Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Etoricoxib Intermediate Revenue Market Share by Countries (2015-2020)
Table 76. Europe Etoricoxib Intermediate Sales by Countries (2015-2020) (MT)
Table 77. Europe Etoricoxib Intermediate Sales Market Share by Countries (2015-2020)
Table 78. Europe Etoricoxib Intermediate Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Etoricoxib Intermediate Sales by Regions (2015-2020) (MT)
Table 80. Asia-Pacific Etoricoxib Intermediate Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Etoricoxib Intermediate Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Etoricoxib Intermediate Sales by Countries (2015-2020) (MT)
Table 83. South America Etoricoxib Intermediate Sales Market Share by Countries (2015-2020)
Table 84. South America Etoricoxib Intermediate Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Etoricoxib Intermediate Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Etoricoxib Intermediate Sales by Countries (2015-2020) (MT)
Table 87. Middle East & Africa Etoricoxib Intermediate Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Etoricoxib Intermediate Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Etoricoxib Intermediate Revenue Market Share by Countries (2015-2020)
Table 90. Global Etoricoxib Intermediate Sales by Type (2015-2020) (MT)
Table 91. Global Etoricoxib Intermediate Sales Share by Type (2015-2020)
Table 92. Global Etoricoxib Intermediate Revenue by Type (2015-2020) (USD Million)
Table 93. Global Etoricoxib Intermediate Revenue Share by Type (2015-2020)
Table 94. Global Etoricoxib Intermediate Sales by Application (2015-2020) (MT)
Table 95. Global Etoricoxib Intermediate Sales Share by Application (2015-2020)
Table 96. Global Etoricoxib Intermediate Sales Forecast by Regions (2021-2025) (MT)
Table 97. Global Etoricoxib Intermediate Market Share Forecast by Regions (2021-2025)
Table 98. Global Etoricoxib Intermediate Sales Forecast by Type (2021-2025) (MT)
Table 99. Global Etoricoxib Intermediate Market Share Forecast by Type (2021-2025)
Table 100. Global Etoricoxib Intermediate Sales Forecast by Application (2021-2025)
Table 101. Global Etoricoxib Intermediate Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Etoricoxib Intermediate Picture
Figure 2. Global Sales Market Share of Etoricoxib Intermediate by Type in 2019
Figure 3. n-House Manufacturing Picture
Figure 4. Contract Manufacturing Organizations Picture
Figure 5. Etoricoxib Intermediate Sales Market Share by Application in 2018
Figure 6. Rheumatoid Arthritis Picture
Figure 7. Psoriatic Arthritis Picture
Figure 8. Osteoarthritis Picture
Figure 9. Ankylosing Spondylitis Picture
Figure 10. Chronic Low Back Pain Picture
Figure 11. Acute Pain Picture
Figure 12. Others Picture
Figure 13. Global Etoricoxib Intermediate Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Etoricoxib Intermediate Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Etoricoxib Intermediate Sales Market Share by Manufacturer in 2019
Figure 34. Global Etoricoxib Intermediate Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Etoricoxib Intermediate Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Etoricoxib Intermediate Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 39. Global Etoricoxib Intermediate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Etoricoxib Intermediate Revenue Market Share by Regions (2015-2020)
Figure 41. Global Etoricoxib Intermediate Revenue Market Share by Regions in 2018
Figure 42. North America Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
Figure 43. Europe Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
Figure 45. South America Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Etoricoxib Intermediate Sales and Growth Rate (2015-2020)
Figure 47. North America Etoricoxib Intermediate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Etoricoxib Intermediate Sales Market Share by Countries (2015-2020)
Figure 49. North America Etoricoxib Intermediate Sales Market Share by Countries in 2018
Figure 50. North America Etoricoxib Intermediate Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Etoricoxib Intermediate Revenue Market Share by Countries in 2018
Figure 52. United States Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 53. Canada Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 54. Mexico Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 55. Europe Etoricoxib Intermediate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Etoricoxib Intermediate Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Etoricoxib Intermediate Revenue Market Share by Countries in 2019
Figure 58. Germany Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 59. UK Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 60. France Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 61. Russia Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 62. Italy Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 63. Asia-Pacific Etoricoxib Intermediate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Etoricoxib Intermediate Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Etoricoxib Intermediate Revenue Market Share by Regions 2019
Figure 66. China Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 67. Japan Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 68. Korea Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 69. India Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 70. Southeast Asia Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 71. South America Etoricoxib Intermediate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Etoricoxib Intermediate Sales Market Share by Countries in 2019
Figure 73. South America Etoricoxib Intermediate Revenue Market Share by Countries in 2019
Figure 74. Brazil Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 75. Argentina Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 76. Middle East and Africa Etoricoxib Intermediate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Etoricoxib Intermediate Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Etoricoxib Intermediate Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Etoricoxib Intermediate Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 81. Egypt Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 82. Turkey Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 83. South Africa Etoricoxib Intermediate Sales and Growth Rate (2015-2020) (MT)
Figure 84. Global Etoricoxib Intermediate Sales and Growth Rate (2021-2025) (MT)
Figure 85. Global Etoricoxib Intermediate Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Etoricoxib Intermediate Market Forecast (2021-2025) (MT)
Figure 87. Europe Sales Etoricoxib Intermediate Market Forecast (2021-2025) (MT)
Figure 88. Asia-Pacific Sales Etoricoxib Intermediate Market Forecast (2021-2025) (MT)
Figure 89. South America Sales Etoricoxib Intermediate Market Forecast (2021-2025) (MT)
Figure 90. Middle East & Africa Sales Etoricoxib Intermediate Market Forecast (2021-2025) (MT)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
関節リウマチ治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Rheumatoid Arthritis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.0% in the forecast period of 2020 to 2025 and will expected to reach USD 8402.6 million by 2025, from USD 7470.1 million in 2019. The Rheum…- 乾癬性関節炎治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Psoriatic Arthritis Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.6% in the forecast period of 2020 to 2025 and will expected to reach USD 9151.4 million by 2025, from USD 6585.3 million in 2019. The Pso…
- 関節リウマチ診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Rheumatoid Arthritis Diagnosis Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.0% in the forecast period of 2020 to 2025 and will expected to reach USD 529.2 million by 2025, from USD 435.8 million in 2019. The R…
- API中間体の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global API Intermediate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The API Intermediate market repo…
- 顔料中間体の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pigment Intermediate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pigment Intermediate mar…